Trial · NCT00458393
Results by group46
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 46
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| HIV Seroconversion | TDF/FTC | 48 | Participants | ||
| HIV Seroconversion | Placebo | 83 | Participants | ||
| Grade 1 or Higher Creatinine Toxicity | TDF/FTC | 32 | Participants | ||
| Grade 1 or Higher Creatinine Toxicity | Placebo | 24 | Participants | ||
| Grade 3 or Higher Phosphorous Toxicity | TDF/FTC | 13 | Participants | ||
| Grade 3 or Higher Phosphorous Toxicity | Placebo | 10 | Participants | ||
| Grade 2, 3, or 4 Laboratory Adverse Events | TDF/FTC | 70 | Participants | ||
| Grade 2, 3, or 4 Laboratory Adverse Events | Placebo | 79 | Participants | ||
| Grade 2, 3, or 4 Clinical Adverse Events | TDF/FTC | 157 | Participants | ||
| Grade 2, 3, or 4 Clinical Adverse Events | Placebo | 162 | Participants | ||
| Hepatitis Flares Among Hepatitis B Virus (HBV) Infected Persons During and After Chemoprophylaxis | TDF/FTC | 0 | Participants | ||
| Hepatitis Flares Among Hepatitis B Virus (HBV) Infected Persons During and After Chemoprophylaxis | Placebo | 0 | Participants | ||
| Percentage Change in Bone Mineral Density | TDF/FTC | L1-L4 Spine bone mineral density | -0.59 | Standard Error 0.21 | percent change from baseline |
| Percentage Change in Bone Mineral Density | Placebo | L1-L4 Spine bone mineral density | 0.32 | Standard Error 0.21 | percent change from baseline |
| Percentage Change in Bone Mineral Density | TDF/FTC | Hip bone mineral density | -0.34 | Standard Error 0.16 | percent change from baseline |
| Percentage Change in Bone Mineral Density | Placebo | Hip bone mineral density | 0.29 | Standard Error 0.16 | percent change from baseline |
| Percentage Change in Body Fat | TDF/FTC | 0.0 | Standard Error 1.0 | percent change from baseline | |
| Percentage Change in Body Fat | Placebo | 3.8 | Standard Error 1.0 | percent change from baseline | |
| Percentage Change in Fasting Triglycerides | TDF/FTC | 0.0 | Standard Error 3.3 | percent change from baseline | |
| Percentage Change in Fasting Triglycerides | Placebo | 0.0 | Standard Error 3.4 | percent change from baseline |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00458393/results